A clinical trial is a research study that tests whether a new medical treatment, medication, or procedure works in real people. For diabetes, clinical trials might test new insulin formulations, oral medications, devices like continuous glucose monitors, or even ways to prevent diabetes in people at high risk. These studies follow strict rules set by the U.S. Food and Drug Administration (FDA) to make sure participants stay safe and researchers collect honest, accurate information.
Get Your Free Guide to Updating Facebook Email →
Clinical trials happen in phases. Phase 1 trials involve a small number of participants and focus mainly on safety and proper dosage. Phase 2 trials expand to more participants and look at whether the treatment actually works. Phase 3 trials involve even larger groups and compare the new treatment to existing ones. Phase 4 trials happen after a drug is approved and on the market, tracking long-term effects in real-world use.
In North Carolina, universities, hospitals, and private research centers conduct diabetes trials. Major medical institutions like Duke University, University of North Carolina at Chapel Hill, and Wake Forest University School of Medicine regularly run studies. Private research clinics in Charlotte, Raleigh, Greensboro, and Wilmington also participate in clinical research networks.
Participants in trials don't pay to join, and many trials offer compensation for time and travel. The compensation varies—some trials pay $50 per visit, others may pay $500 or more depending on how involved the study is. Beyond payment, participants may gain access to new treatments before they're available to the general public, and they receive careful medical monitoring throughout the study.
Practical takeaway: Understanding what clinical trials are and how they work helps you make informed decisions about participation. Trials are structured research studies with safety oversight, not experimental treatments with unknown risks.
Type 1 diabetes trials in North Carolina focus on several areas. Some study ways to preserve remaining pancreatic function in newly diagnosed patients. Others test artificial pancreas systems that automatically adjust insulin delivery based on blood sugar levels. Immunotherapy trials investigate whether drugs that regulate the immune system can slow or stop the autoimmune destruction of insulin-producing cells. The JDRF (Juvenile Diabetes Research Foundation) and NIH (National Institutes of Health) fund many of these studies across North Carolina's medical centers.
Get Your Free Medicare Dermatologist Coverage Guide →
Type 2 diabetes trials test different medication classes, lifestyle interventions, and combination therapies. Trials might compare newer medications like GLP-1 agonists (such as semaglutide) to older diabetes drugs, measuring which helps more people reach their blood sugar targets with fewer side effects. Some trials focus on preventing type 2 diabetes in people with prediabetes. Duke University has run several large-scale prevention trials in rural North Carolina communities.
Device-based trials include studies of continuous glucose monitoring systems, insulin pumps with smart features, and non-invasive glucose measurement devices. These trials test how well devices work in daily life, how accurate they are, and whether they improve quality of life for people with diabetes. Some trials combine devices with mobile apps that help people track patterns and share data with their doctors.
Pregnancy and gestational diabetes trials address the needs of pregnant women or those planning pregnancy. These studies might test new insulin formulations safe for pregnancy, medications to prevent gestational diabetes in high-risk women, or ways to improve blood sugar control in women with existing diabetes who are pregnant. UNC Chapel Hill and Duke have maternal-fetal medicine programs running relevant studies.
Complication-prevention trials investigate treatments for diabetic neuropathy (nerve damage), retinopathy (eye damage), and kidney disease. Rather than testing diabetes medications themselves, these trials test drugs that might slow or prevent damage from high blood sugar. Someone with diabetes for 15 years but no complications might be recruited for a preventive trial; someone with early kidney damage might join a trial testing a kidney-protective medication.
Practical takeaway: North Carolina offers trials across many diabetes types and research areas. Knowing what types of trials exist helps you identify studies that match your diabetes type and health situation.
ClinicalTrials.gov is the official U.S. government database of clinical trials. You can visit the website and search for "diabetes" combined with "North Carolina." The site lists trials recruiting participants, trials currently enrolling, and trials that have closed. Each trial listing includes the study title, what the trial tests, basic requirements, location, and contact information. The search is free and doesn't require registration.
Learn Basic Drawing Techniques for Beginners →
The JDRF website maintains a trial finder specifically for type 1 diabetes research. Visit jdrf.org and use their "Find a Trial" tool. You can filter by location, diabetes type, and what the trial is studying. This resource focuses on type 1 diabetes but occasionally includes related research.
The American Diabetes Association (ADA) provides information about trials through their website. While they don't maintain a separate trial database, their "Living with Diabetes" section includes resources about research participation and links to other trial-finding tools.
University medical centers and hospital systems maintain their own research websites. Duke University School of Medicine has a clinical trials office. UNC Chapel Hill has a research recruitment page listing active diabetes studies. Wake Forest School of Medicine lists trials through their research portal. Atrium Health in Charlotte and Cone Health in Greensboro operate research departments that post about ongoing studies.
Private research centers and community clinical research networks in North Carolina recruit for trials. Companies like Velocity Clinical Research operate multiple sites across the state in Charlotte, Raleigh, and Greensboro. These centers often focus on phase 2 and phase 3 trials and have experience enrolling diverse participant populations.
Your personal healthcare provider can tell you about trials relevant to your situation. Endocrinologists and primary care doctors often know about studies recruiting at their institution or nearby. Some diabetes educators and certified diabetes care and education specialists (CDCES) maintain lists of current trials for their patients.
Pharmaceutical companies conducting diabetes research advertise trials directly. Sites like Trial Match, ResearchMatch, and specific drug manufacturer websites list studies. These sites allow you to create a profile and be contacted about matching trials.
Practical takeaway: Multiple databases and resources exist to find trials. Start with ClinicalTrials.gov as a comprehensive source, then use disease-specific sites like JDRF for more targeted results.
Each trial has specific requirements that potential participants must meet. These requirements exist to make sure the research answers its intended questions and to protect participant safety. Common requirements include age (some trials require adults 18 and older; others target specific age groups), diabetes type and duration (a trial might need people with type 2 diabetes diagnosed within the last five years, or type 1 diabetes for at least 10 years), and blood sugar control level measured by hemoglobin A1c.
Get Your Free Guide to Rhode Island EBT Card Balance →
Medical history matters significantly. If you take certain medications, have other health conditions, or had previous reactions to similar drugs, you might not be able to join specific trials. Pregnancy status, smoking history, and kidney or liver function are often relevant. Trials testing devices might require stable vision or adequate manual dexterity. Some trials need participants with no complications; others specifically recruit people with established complications.
Participation typically involves multiple visits over weeks or months. A single-visit trial might occur in one day. Most trials require at least monthly visits for 3 to 12 months. Some long-term studies continue for years. Each visit might include blood draws, blood pressure checks, questionnaires, physical exams, or device use. A typical visit lasts 1 to 3 hours depending on what procedures are done.
During the trial, you'll likely need to keep a diary or log information about blood sugar readings, meals, exercise, or medication doses. Some trials use apps on your phone; others use paper logs. You might need to wear monitoring devices, give multiple blood samples, or have imaging studies like ultrasound or MRI. Trials testing medications require you to take them exactly as directed and report any side effects promptly.
Restrictions vary by trial. Some require you to avoid certain foods or supplements. Others might limit exercise or require specific sleep schedules during the study. If the trial tests a new medication, you typically cannot take other related medications during that time. Some trials require you to stay off blood pressure medications or diabetes medications for specific periods—but only if safe to do so and under medical supervision
This guide is for general information only and is not medical, financial, legal, or other professional advice. For decisions specific to your situation, consult a qualified professional. See our Editorial Policy.